A detailed history of Bell Investment Advisors, Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 111 shares of DVAX stock, worth $1,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111
Previous 155 28.39%
Holding current value
$1,411
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.05 - $11.61 $442 - $510
-44 Reduced 28.39%
111 $1,000
Q3 2023

Nov 08, 2023

BUY
$12.64 - $14.99 $758 - $899
60 Added 63.16%
155 $2,000
Q2 2023

Aug 09, 2023

BUY
$9.85 - $13.17 $433 - $579
44 Added 86.27%
95 $1,000
Q1 2023

May 10, 2023

BUY
$9.44 - $11.88 $481 - $605
51 New
51 $0

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.